Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 Study - Colucci, G; Labianca, R; Di Costanzo, F (J Clin Oncol, 2010)
et al.